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Abstract
Background: Multimorbidity is an intuitively appealing, yet challenging, concept for Family Medicine (FM). An
EGPRN working group has published a comprehensive definition of the concept based on a systematic review of
the literature which is closely linked to patient complexity and to the biopsychosocial model. This concept was
identified by European Family Physicians (FPs) throughout Europe using 13 qualitative surveys. To further our
understanding of the issues around multimorbidity, we needed to do innovative research to clarify this concept.
The research question for this survey was: what research agenda could be generated for Family Medicine from the
EGPRN concept of Multimorbidity?
Methods: Nominal group design with a purposive panel of experts in the field of multimorbidity. The nominal
group worked through four phases: ideas generation phase, ideas recording phase, evaluation and analysis phase
and a prioritization phase.
Results: Fifteen international experts participated. A research agenda was established, featuring 6 topics and 11
themes with their corresponding study designs. The highest priorities were given to the following topics:
measuring multimorbidity and the impact of multimorbidity. In addition the experts stressed that the concept
should be simplified. This would be best achieved by working in reverse: starting with the outcomes and working
back to find the useful variables within the concept.
Conclusion: The highest priority for future research on multimorbidity should be given to measuring
multimorbidity and to simplifying the EGPRN model, using a pragmatic approach to determine the useful variables
within the concept from its outcomes.
Background
The number of people suffering from multiple conditions
(multimorbidity) is rising rapidly especially in family medi-
cine (FM) [1]. The concept of multimorbidity was first
described in the 1970s [2]. It was, at that time, an addition
to the concept of comorbidity, with the intention of
looking at all the conditions in one individual [3–5].
Nevertheless, the concept remained unclear, especially for
research and practical purposes [6, 7]. The World Health
Organisation (WHO), in 2008, tried to clarify the concept
and defined Multimorbidity as people being affected by
two or more chronic health conditions [8]. The intention
of the WHO was to look at all conditions in one individ-
ual that could impact on that individual’s global health sta-
tus. However the word’condition’ was not sufficiently clear
for research or practical purposes (for instance, whether a
treated disease was a ‘condition’ in this sense), and could
lead to numerous interpretations.
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Despite those interpretations, multimorbidity is a very
interesting and challenging concept, particularly for FM
and long-term care, given the increasing prevalence of
chronic illness in an aging population across all countries.
It is closely related to a global or comprehensive view of
the patient, which is a core competency of FM, as defined
for instance by the World Organization of National Col-
leges, Academies and Academic Associations of General
Practitioners/Family Physicians (WONCA) [9]. It is also a
global ‘functional’ or ‘goal-oriented’ view (useful for Long-
Term Care) versus a ‘disease’ centered point of view
(useful for acute care). Nevertheless, the disease centered
point of view remains the basis of most clinical guidelines
even if it is not fully applicable in FM [10, 11].
The European General Practice Research Network
(EGPRN) was very interested in the concept of multimor-
bidity as this network is committed to concepts that could
advance research and practice in primary care throughout
Europe. The EGPRN has created a research agenda specif-
ically designed for methodological and instrumental
research, which includes the development of primary care
epidemiology, focusing on patient-centered health [12]. A
clear definition of the concept of multimorbidity (i.e., one
which is both understandable and usable for further
collaborative research) is an important objective for a
research network of this type. It aims to help researchers
in FM to investigate the complexity of patients’ conditions
and their overall impact on patients’ health. A clear defin-
ition of multimorbidity could be an additional tool for
Family Physicians (FPs), enabling them to identify frail
patients and prevent decompensation [13]. A specific
research agenda could be developed for multimorbidity.
A research group, including 9 national groups, all active
within the EGPRN, has created a research community for
the purpose of clarifying the concept of multimorbidity
for FM throughout Europe [14]. An initial review, pre-
sented in an EGPRN meeting in spring 2011 [15], identi-
fied more than one hundred different definitions used by
academic researchers. Such a large number of definitions
added more confusion than clarification to the discussion
and led the group to the production of a comprehensive
definition of the concept of multimorbidity with the help
of a systematic review of literature [16].
It was then necessary to assess whether Family Physi-
cians (FPs) recognized this concept, which had emerged
from medical research, as applicable to their complex
patients. FPs are well-placed to identify this concept as
they aim to be more aware of their patients’ expectations
than other specialists [17] and they are used to dealing
with complex patients [18, 19]. In order to make this as-
sessment, the comprehensive definition of Multimorbidity
was carefully translated into 10 European languages with
the help of a forward-backward translation procedure using
a Delphi consensus methodology [20]. Those translated
definitions were presented to European FPs with 13 con-
secutive qualitative surveys, designed to check how the FPs
experienced and worked with the developed concept of
multimorbidity and whether this was fully consistent with
the definition. European FPs clarified the concept and
added the role of gut feelings, core competencies of FM,
and patient and doctor experience, to the management of
Multimorbidity. A comprehensive concept of multimorbid-
ity for FM was then established.
Researchers in the field of multimorbidity explored
innovative research topics, themes, questions and appro-
priate design formats in relation to the concept of Multi-
morbidity for FM, leading to the question: what research
agenda could be generated for Family Medicine from the
EGPRN concept of Multimorbidity?
Methods
For this study we used a qualitative research method, i.e.,
a nominal group technique (NGT) [21]. This technique
was chosen because multimorbidity is conceptually com-
plex. The NGT enables researchers to gather information
from relevant experts [22, 23]. NGT facilitates creative
problem solving by means of judgmental decision making
in situations where routine answers are inadequate [24].
With an NGT, it is possible to plan research through
group meetings or by email [25]. The ethical committee of
the “université de Bretagne occidentale” gave the ethical
approval for the whole process as this university led the
study. Informed consent was obtained from all partici-
pants even if it was a non-interventional study. NGT is a
well-known technique that has already been used by
members of the research group [26].
With an international group, adaptations were needed
and an email system was used as it had already been
successfully employed in several earlier studies [27–29].
An NGT involves four phases: ideas generation phase,
ideas recording phase, evaluation and analysis phase and
a prioritization phase.
Type of participants and selection of experts
An international panel of experts in the field of multimor-
bidity was purposively sampled. The NGT does not
require a fixed number of experts in order to be valid but
does require relevant experts. To be relevant, those
experts should have prior experience in the field of the re-
search in question (multimorbidity, FM, patient-centered
care). The group was selected from three backgrounds:
The EGPRN, the Threads and Yarns network members
(a group designed for research into the field of multi-
morbidity), and researchers in multimorbidity from
Polish, Dutch and British Universities. The group was
made up of FM clinicians, researchers in FM and
linguistics, methodologists and epidemiologists. Some
individuals were involved in two different groups. 18
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experts were approached by email. 18 were willing to
cooperate and received written information. We invited
them to participate and 15 accepted. Reasons for de-
clining were prior engagements and illness.
NGT sessions
For ideas generation, experts were asked to read the publi-
cations about the concept of Multimorbidity produced by
the EGPRN (protocol [14], systematic review [16], transla-
tions [20] and qualitative surveys). Then they were asked
to take time and write down what they regarded as the
main research questions relating to the “concept of Multi-
morbidity issued by the EGPRN”. At the same time, they
were asked to present an appropriate design for each
research question, with a commentary to make it easily
understandable by each participant. Each expert could
produce a maximum of five propositions, arising from
that definition, with a design and a commentary for each.
The aim was to leave this process wide open in order to
elicit the widest possible variety of responses.
In the ideas recording phase participants were engaged
in a round-robin feedback system by email. All the propo-
sitions were sorted, with their designs and commentaries,
and classified to detect duplicates. Duplicates were sum-
marized and sent back to the planners to check that they
were compatible with the planners’ initial intentions.
Where necessary, corrections were made to the questions,
designs and commentaries.
The evaluation and analysis phase was undertaken to
identify and clarify research topics and themes and to
develop designs. All the propositions were classified into
research topics and themes and then summarized by an
independent group of 6 researchers from the SPURBO
research team (Université de Bretagne Occidentale).
These 6 researchers’ propositions were sent to all partic-
ipants for agreement before any further development.
Then designs were developed, for each research theme
and topic, by their proposers. The designs were sent
back to all the participants for analysis. Where neces-
sary, it was possible to have open discussions, by email,
between members so that submitted propositions could
be clarified. These emails were sent out to all the partici-
pants so that all the members received clarification on
each proposition.
The intention of the prioritization phase was to aggre-
gate the judgment of the experts in order to determine
the relative importance of the research questions, and
corresponding designs for future research relating to the
concept of Multimorbidity produced by the EGPRN. All
participants were asked to rank the propositions, accord-
ing to the level of importance they attached to them, for
FM and patient centered care. They had the opportunity
to apply 3 scores: a score of 5 points for one proposition,
a score of 3 points for another and a score of 1 point for
the final proposition. A prioritized list of all the proposi-
tions was drawn up from these scores. This prioritized
list was sent back to all the participants in order to
evaluate the procedure and the outcomes and to collect
objections, should any arise.
Results
Description of participants
In total, 15 experts participated in the study, 7 men and
8 women from different countries, including Bulgaria,
Croatia, France, Germany, Greece, Italy, Poland, Spain
and the UK. Their average age was 49 years (ranging
from 35 to 62 years). All clinicians (14 out of 15) had an
average of 19.8 years’ practice experience (ranging from
4 to 33 years), with 10 working in group practices,
mostly in urban areas. Methodologists, linguists and epi-
demiologists were also experienced, with an average of
38.5 published articles. They all had experience of pub-
lishing articles, with an average of 34 published articles
(ranging from 6 to70), of which an average of 16 were in
English (ranging from 3 to 65). Participants had had an
average of 5 articles published with multimorbidity as a
major topic (ranging from 1 to15).
Description of results
The ideas generation and ideas recording phase pro-
duced 61 research questions and study designs after
duplicates had been withdrawn. Although there was con-
siderable overlap in the ideas, the evaluation and analysis
phase aggregated those 61 research questions into 11
themes, including 6 major topics, with their attached
research questions and designs. The prioritization phase
produced a consensual ranking of the topics and themes.
The total score possible, by adding up the points of all
15 experts, was 135. Topics, themes and study design,
with their ranking, are described in Table 1 below.
The research questions suggested for the multimorbid-
ity research agenda are listed, by topic, in Table 2 below.
Discussion
Main findings
With the help of a nominal group technique, the re-
search team was able to establish a research agenda on
Multimorbidity in Family Practice. 6 topics and 11
themes were listed with their corresponding designs (see
Table 1). Overall, the highest priorities were given to the
following topics: measuring Multimorbidity and the im-
pact of Multimorbidity (see Table 2).
The measurement of Multimorbidity is seen as the
most important topic when totaling the votes for the dif-
ferent themes included. The impact of Multimorbidity
on patient or health outcomes is seen by the research
group as the most important theme for future research,
even if it is included in the second topic to research
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(Impact of Multimorbidity). The management of multi-
morbidity in practice is seen as the third most important
topic.
Interpretation
The measurement of Multimorbidity has been explored
considerably over the past 10 years and has often been
divergent as the authors did not use the same definition
of this concept [7, 30]. With the EGPRN concept of
multimorbidity, this pitfall could be avoided, especially if
an expert consensus could be obtained on the effect of
the burden of diseases on multimorbidity (see Table 1).
The effect of the burden of diseases on multimorbidity
was a secondary research theme in this survey (7th
theme to be researched) but could also be of major im-
portance for the measurement of Multimorbidity. Al-
though it has already been the subject of many studies
[30, 31], practitioner input has, so far, been limited. Most
of our experts are also practicing FPs and confirm the
importance of this topic.
An alternative way of measuring multimorbidity, for this
study’s experts, was to determine the impact of multimor-
bidity on negative health outcomes (such as frailty, depres-
sion, cost of care, health service use). The impact of
multimorbidity was, according to the experts in this study,
for the patient, the clinical, negative result of being Multi-
morbid. It is a reverse way of determining multimorbidity.
The burden of diseases could determine whether a patient
is multimorbid and the impact of multimorbidity will
determine the effect of multimorbidity on a patient’s life.
This alternative route could lead a research team to define
the most effective variables that contribute to the concept
of multimorbidity to help prevent those negative out-
comes. In addition, it could simplify the concept when it
is aimed at a specific outcome, to help clinicians in every-
day practice. This was an attractive issue for most experts.
It could resolve the debate about measuring a concept as
broad as multimorbidity seems to be. Many studies have
been conducted to assess the relationship between multi-
morbidity and health outcomes but without solving the
problem of the meaning and the intensity of that relation-
ship [32, 33].
The results underline the usefulness of the patient’s
perception of his/her own multimorbidity which could be
an alternative way to weigh and measure multimorbidity.
This perception has rarely been explored [34]. The experts
emphasized this fourth topic for future research and its
importance for them. They were stimulated by their own
practice experience and by their need to integrate the
patients’ perspective as a key element of the decision
Table 1 Topics, Themes and design ranked by participants’ votes
Topics, themes and designs for multimorbidity Agenda









Epidemiology of Multimorbidity Expert consensus or cross
sectional or cohort
18
Impact of (or on) Multimorbidity Impact of multimorbidity on frailty
or health outcomes, or cost of care, or
health service utilization, or depression.
Cohort 38 40
Impact of socioeconomic status on
multimorbidity
Cross sectional or cohort 2





Patient Doctor relationship evaluation
in the management of multimorbidity
Cross sectional 5
FP workload and burden of multimorbidity Cross sectional 3
Patient perspective Multimorbid patient's perspective Qualitative study (semi directed
interviews or focus groups)
8 13





Links between complexity and
multimorbidity
Multimorbidity definition as a help to detect
complexity
Cross sectional 6 6
Stakeholders’ perspective Consensus for multimorbidity research
according to stakeholders’ interest
Expert consensus 3 3
Total votes 135 135
Experts had 9 points to allocate (5 for their first top theme, 3 for the second, 1 for the third). They were 15 experts with a maximum of 135 points to allocate.
Top three research themes are the first three. All the others are secondary research themes
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Table 2 Proposed research questions for the different topics and themes
Proposed research questions for the different topics and themes
Topics Themes Research question examples
Measuring multimorbidity Developing or finding
measurement tool for
multimorbidity
What tool could be designed using the definition of
multimorbidity to enhance medical decision making
(including shared decision-making)? Then design an
application to be implemented in electronic medical
records and evaluate that tool’s effectiveness in
decision-making.
Epidemiology of multimorbidity Are there clear trends in the development of multimorbidity
at the individual (patient) level? What are the predictors of
multimorbidity and are there any specific patterns of accumulation?
Are there specific patterns and conditions which are likely to
accelerate the development of multimorbidity? Evaluation of
MM in EU countries? Would it be possible to measure the
different levels of multimorbidity in order to describe the
patient's complexity?
Impact of multimorbidity Impact of multimorbidity
on patient or health service
outcomes.
Have the different criteria included in the definition of
multimorbidity different predictive powers in terms of
patient outcomes (Mortality, health status, frailty, health
outcomes decline, poly-pharmacy, depression) or health
system outcomes (cost of care or poly-pharmacy or health
services utilization)? With an additional question for depression:




What is the Impact of multimorbidity on particular groups
(low socioeconomic status, addictive persons, societies in
economic crisis)? What is the role of socioeconomic
differences in multimorbidity?
Management of multimorbidity Multimorbidity management
in General Practice
What are the methods to promote medical audit in
patients with multimorbidity? How does multimorbidity
influence FP management? How can medical records
of co-morbid patients be improved?
Patient Doctor relationship
evaluation in the management
of multimorbidity
Is the doctor- patient relationship a modifying factor in
the concept of multimorbidity? This study will take into
account communicative challenges, including, not only
FPs’ communicative skills/ communicative competence,
but in particular, FPs’ ability to cope with their own
emotions and the patients’ emotions.
FP workload and burden
of multimorbidity
Do FPs of multimorbid patients have an unchanged
quality of life when their patients' multimorbidity increases?
Selecting groups of FPs according to their patients’
multimorbidity, using the definition of multimorbidity
and comparing their quality of life.
Patient perspective Multimorbid patient's
perspective
How do patients conceptualize the multimorbidity
condition using their own language, concepts,
metaphors, and expectations? With the intention of
looking at the impact of multimorbidity on patients’
experiences of self-management and health care




What is the role of the patient perceived burden of
diseases into the multimorbidity definition? Is the burden
of disease, as perceived by the patient, a modifier of
multimorbidity or should it be included in the defining
illnesses? Is it possible to assert that only diseases with
a burden should be considered to contribute to
multimorbidy? (For example, not a healed cataract or
stabilized hypertension).
Links between complexity and multimorbidity Multimorbidity definition as a
help in detecting complexity
How could the concept of multimorbidity improve
the ability to detect complex patients in family medicine?
As risk factors, guidelines and recommendation for
secondary prevention are well defined for cardiovascular
diseases and diabetes mellitus, the aim of the study might
be to identify the level of comorbidity (in terms of complexity)
in these patients, to define barriers, to follow preventive activities
which are well defined by European associations of cardiologists
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making process. They felt that the patient’s perception
was one way to enhance the coping strategies of the
patient which is of importance in the EGPRN definition of
multimorbidity: to lower the level of multimorbidity.
How to improve the management of multimorbidity in
everyday practice seemed of importance to our experts, as
a research theme, and this management focus could be
linked to patient complexity, as both are important issues
for family medicine. Using the concept of multimorbidity
as an aid for detecting and managing patient complexity
may be a new pathway for research.
The final topic took into account all the stakeholders’
perspectives, which should be incorporated into all the
research, as stakeholders reflect population needs [4].
Strengths and limitations
Nominal group technique has already been used as a
method to generate ideas for study designs [35]. It is an ef-
ficient technique to gather specific ideas about difficult re-
search questions. The benefit of nominal group technique
is that all experts have an equal opportunity to participate
and influence the decision. It reduces the conforming
common influence of face-to-face group meetings.
The study team tried to be as open as possible in the
data collection. Information bias was limited as all the
experts had open access to all the information. This bias
was still possible because their prior researches in the field
of multimorbidity could influence their prioritization. To
handle that possible bias, throughout the entire process,
the research team stimulated open discussion and inter-
action through regular face-to-face meetings. Selection
bias was limited by the use of a pan-European panel of
researchers, with real experience of multimorbidity re-
search, assessed by specific publications, as well as experi-
ence in practicing as FPs.
Implications
Results allow researchers to start relevant and, it is hoped,
high-quality studies using the EGPRN concept of multi-
morbidity, avoiding difficulties previously encountered in
research into multimorbidity, to detect and measure it in
practice. They highlight the connection between multi-
morbidity and complexity which could lead to specific
recommendations for the complex patients, often seen in
Family Medicine, whose situation has rarely been explored
in research up to now. They increase the possibility of
using reverse methods, starting from the outcomes, or the
patient’s perspective, or the stakeholder’s perspective, and
working back to the variables in the concept which are
useful for research, in order to create pragmatic models
for multimorbidity.
They also open up a new aim for practitioners: multi-
morbidity could help them in managing patients, by
using a more holistic and goal-oriented approach as the
EGPRN concept of multimorbidity is closely related to
the biopsychosocial model [36]. The aim would be to
place the exchange with the patient at the center of the
clinical consultation process rather than allocate it a
supporting role [37].
They also open new perspectives in medical education,
focusing on the patient’s perspective which is a core com-
petency for Family Practice, as specified in the WONCA
Family Practice competencies [9].
Conclusion
Using a Nominal Group technique, a research agenda is
now available for further research into Multimorbidity.
The highest priority should be given to measuring multi-
morbidity and to simplifying this model, using the out-
comes of a pragmatic approach to determine the useful
variables of this concept.
Table 2 Proposed research questions for the different topics and themes (Continued)
and diabetologists. It can be measured from the
FP’s perspective, and specific diseases perspective
and from the patient’s perspective), with the aim
of formulating more specific recommendation for
the preventive and curative care of multimorbid
patients with cardiovascular diseases.
Stakeholders’ perspective Consensus for multimorbidity
research according to
stakeholders’ interest
Are stakeholders interested in the patient’s perspective
(multimorbidity: perceived severity and grading,
self-management and individualized patient-centered plan)
or health professional’s perspective (operational definition
of MM, improvement of clinical decision support, practice-based
guidelines in multimorbidity and poly-pharmacy) or in
research perspective (gaps in multimorbidity research,
consensus-based set of recommendations for inclusion and
reporting of multimorbid patients in Randomized Controlled
Trials, and for addressing multimorbidity in Clinical
Practice Guidelines)
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